the Role of Two Different Metronomic Chemotherapy Regimens in Locally Advanced or Metastatic Triple Negative Breast Cancer Patients (TNBC) as Maintenance Therapy After First Line Treatment
Clinical trial NCT03358004 · TERMINATED
Trial details
- NCT number
- NCT03358004
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-14
- Primary completion
- 2018-09-13
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.